These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

678 related articles for article (PubMed ID: 1850498)

  • 1. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).
    Warrell RP; Frankel SR; Miller WH; Scheinberg DA; Itri LM; Hittelman WN; Vyas R; Andreeff M; Tafuri A; Jakubowski A
    N Engl J Med; 1991 May; 324(20):1385-93. PubMed ID: 1850498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rearrangements of the retinoic acid receptor alpha and promyelocytic leukemia zinc finger genes resulting from t(11;17)(q23;q21) in a patient with acute promyelocytic leukemia.
    Chen SJ; Zelent A; Tong JH; Yu HQ; Wang ZY; Derré J; Berger R; Waxman S; Chen Z
    J Clin Invest; 1993 May; 91(5):2260-7. PubMed ID: 8387545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Remission of acute promyelocytic leukemia after all-trans-retinoic acid].
    Knobel B; Sommer I; Meytes D
    Harefuah; 1992 Dec; 123(11):445-8, 507. PubMed ID: 1487198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. All-trans retinoic acid for acute promyelocytic leukemia. Results of the New York Study.
    Frankel SR; Eardley A; Heller G; Berman E; Miller WH; Dmitrovsky E; Warrell RP
    Ann Intern Med; 1994 Feb; 120(4):278-86. PubMed ID: 8291820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poor response to all-trans retinoic acid therapy in a t(11;17) PLZF/RAR alpha patient.
    Guidez F; Huang W; Tong JH; Dubois C; Balitrand N; Waxman S; Michaux JL; Martiat P; Degos L; Chen Z
    Leukemia; 1994 Feb; 8(2):312-7. PubMed ID: 8309256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Proposals for the objective indices for evaluating the differentiation of leukemic cells by all-trans retinoic acid in the patients with acute promyelocytic leukemia].
    Nakajima H; Kizaki M; Takayama N; Kawai Y; Watanabe K; Okamoto S; Ikeda Y
    Rinsho Ketsueki; 1996 Mar; 37(3):208-13. PubMed ID: 8727344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic reversion in acute promyelocytic leukemia.
    Degos L
    Nouv Rev Fr Hematol (1978); 1991; 33(6):511-5. PubMed ID: 1667950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinoic acid and its rearranged receptor in the etiology and treatment of acute promyelocytic leukemia.
    Frankel SR; Miller WH; Dmitrovsky E
    Oncology (Williston Park); 1992 Aug; 6(8):74-78, 83; discussion 84, 87-8. PubMed ID: 1323988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remission induction of acute promyelocytic leukemia by all-trans-retinoic acid: molecular evidence of restoration of normal hematopoiesis after differentiation and subsequent extinction of leukemic clone.
    Ohashi H; Ichikawa A; Takagi N; Hotta T; Naoe T; Ohno R; Saito H
    Leukemia; 1992 Aug; 6(8):859-62. PubMed ID: 1353552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis and management of acute promyelocytic leukemia.
    Warrell RP
    Annu Rev Med; 1996; 47():555-65. PubMed ID: 8712802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. All-trans-retinoic acid treatment and retinoic acid receptor alpha gene rearrangement in acute promyelocytic leukemia: a model for differentiation therapy.
    Degos L
    Int J Cell Cloning; 1992 Mar; 10(2):63-9. PubMed ID: 1312109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low-dose chemotherapy, PMN/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid.
    Vahdat L; Maslak P; Miller WH; Eardley A; Heller G; Scheinberg DA; Warrell RP
    Blood; 1994 Dec; 84(11):3843-9. PubMed ID: 7949141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of retinoid resistance by all-trans retinoic acid in acute promyelocytic leukemia after remission.
    Cornic M; Chomienne C
    Leuk Lymphoma; 1995 Jul; 18(3-4):249-57. PubMed ID: 8535190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. All-trans-retinoic acid in acute promyelocytic leukemia.
    Tallman MS; Andersen JW; Schiffer CA; Appelbaum FR; Feusner JH; Ogden A; Shepherd L; Willman C; Bloomfield CD; Rowe JM; Wiernik PH
    N Engl J Med; 1997 Oct; 337(15):1021-8. PubMed ID: 9321529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia.
    Muindi J; Frankel SR; Miller WH; Jakubowski A; Scheinberg DA; Young CW; Dmitrovsky E; Warrell RP
    Blood; 1992 Jan; 79(2):299-303. PubMed ID: 1309668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanism of action of retinoids in a new therapeutic approach to acute promyelocytic leukemia].
    Cornic M; Guidez F; Delva L; Agadir A; Degos L; Chomienne C
    Bull Cancer; 1992; 79(7):697-704. PubMed ID: 1334741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoic acid in acute promyelocytic leukemia: the promise and the paradox.
    Clarkson B
    Cancer Cells; 1991 Jun; 3(6):211-20. PubMed ID: 1911035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosome observations of acute promyelocytic leukemia treated with all-trans retinoic acid.
    Wu X; Wang WW; Zhou ZL; Zhu GC; Yang ZC; Ying JS; Zhu Y
    Hematol Pathol; 1992; 6(1):25-9. PubMed ID: 1601819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute promyelocytic leukemia. The therapeutic advances].
    de Lacerda JF; do Carmo JA; de Lacerda JM
    Acta Med Port; 1993 Oct; 6(10):473-80. PubMed ID: 8285119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PML-RAR alpha fusion transcripts by RNA PCR in acute promyelocytic leukemia in remission and its correlation with clinical outcome.
    Ikeda K; Sasaki K; Tasaka T; Nagai M; Kawanishi K; Takahara J; Irino S
    Int J Hematol; 1994 Oct; 60(3):197-205. PubMed ID: 7858239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.